Floatz logo

Pyrotinib

Liver Transplant; Complications

RenJi HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Liver Transplant; Complications cohort.

Asset / SponsorPhaseRating
Giapreza
University of California, San Francisco
Phase 4BBB
Sitagliptin
University Health Network, Toronto
Phase 4BB
Noradrenaline
University of California, Los Angeles
Phase 4BB
Envarsus Product
University of Alberta
Phase 4BB
Semaglutide
University Health Network, Toronto
Phase 4BB

View all 14 →

Same molecule, other indications

Pyrotinib is also rated in:

Non Small Cell Lung CancerDormant
BB
Indicative ·
70 / 100
View asset →
breast carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →